Surface Oncology, Inc.
Anti-CD47 antibodies and methods of use
Last updated:
Abstract:
Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
Status:
Grant
Type:
Utility
Filling date:
21 Sep 2017
Issue date:
15 Oct 2019